In such a way, an anti-Kv10.1 mAb (mAb62) was used to target tumor cells in vitro using the human breast MDA-MB-435S cell line and in vivo on tumor models of nude mice (Napp et al., 2016). The gene discussed is KCNH1; the disease is neoplasm.